Filing Flows › Abeona Therapeutics (ABEO) › Q2 2026 › vs Q2 2025
Abeona Therapeutics (ABEO) Q2 2026 vs Q2 2025 (year over year)
Abeona Therapeutics's revenue rose $11.0M (28×) from $400K in Q2 2025 to $11.4M in Q2 2026.
Abeona Therapeutics, Q2 2026: revenue $11.4M (28× year over year), operating margin -120.0%, net loss $20.2M, operating cash flow −$17.5M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $11.4M | $400K | $11.0M | 28× |
| Net loss | $20.2M | −$109M | $129M | — |
| Costs & expenses | $31.6M | $148M | −$116M | -79% |
| Operating costs | $25.0M | $23.2M | $1.8M | +8% |
| Interest & other, net | $6.5M | −$147M | $154M | — |
| Research & development | $5.0M | $5.9M | −$922K | -16% |
| SG&A | $15.8M | $17.1M | −$1.3M | -8% |
| Operating cash sources | $21.5M | $22.2M | −$628K | -3% |
| Depreciation & amortization | $665K | $544K | $121K | +22% |
| Share-based compensation | $3.4M | $2.8M | $539K | +19% |
| Cash used in operations | $17.5M | $18.8M | −$1.3M | -7% |
| Net loss absorbed | $20.2M | −$109M | $129M | — |
| Working capital & other | $1.3M | $131M | −$130M | -99% |
Questions
How much did Abeona Therapeutics's revenue grow year over year in Q2 2026?
Abeona Therapeutics's revenue rose $11.0M (28×) from $400K in Q2 2025 to $11.4M in Q2 2026.